@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns2:C0030705 "patients"; ns2:C4726677 "remdesivir" . rdf:predicate ns1:TRIPLE_UID:81qoau7o-TRIPLE-ABSTRACT-1 "administer" . rdf:subject ns2:C0011777 "dexamethasone"; ns2:C0019134 "heparin"; ns2:C0770546 "heparin"; ns2:C0907850 "ciclesonide"; ns2:C1138226 "Favipiravir"; ns2:C5237592 "heparin" . rdfs:Triple-UID ns3:TRIPLE_UID:81qoau7o-TRIPLE-ABSTRACT-1 "81qoau7o-TRIPLE-ABSTRACT-1" . rdfs:sentence rdfs:label "Favipiravir, ciclesonide, dexamethasone, and heparin were administered in 106, 168, 65, and 38 patients, respectively, but not remdesivir." . rdfs:triple rdfs:label "Favipiravir , ciclesonide , dexamethasone , and heparin administered in 106 , 168 , 65 , and 38 patients , respectively , but not remdesivir" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:46:25.209413"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "MtJszUpV5Hk2RHJU1H7FkLgeJ1yS6+fbN0bDzZhHbV547/VxGI7kfC/FO/feZzG/Iw/5Up873vR8XXYm6EUSO49JRHIiyIRqaup3NtyynF088IC0UAFEpKSdBEMuaqZrGfrC4pNOIfnD+8f52Klk/nt24kgSdxRzENRaHcVlk+M="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:46:25.209413"^^xsd:dateTime; prov:wasAttributedTo . }